v3.6.0.2

Concentration of Risk | 12 Months Ended
--- | ---
Nov. 30, 2016
Risks and Uncertainties [Abstract] |
CONCENTRATION OF RISK | CONCENTRATION OF RISK Most of the Company’s products are sold to major drug and food chains merchandisers, and wholesale beauty-aids distributors throughout the United States and Canada. During the fiscal years ended November 30, 2016, 2015 and 2014, certain customers each accounted for more than 5% of the Company’s net sales, as follows:
|  | For the Year Ended November 30,
Customer |  | 2016 |  | 2015 |  | 2014
Walmart |  | 38.7 | % |  | 34.6 | % |  | 47.0 | %
Walgreens |  | 10.5 | % |  | 13.4 | % |  | 6.5 | %
Target |  | 8.6 | % |  | 7.2 | % |  | * |
CVS |  | * |  |  | 5.7 | % |  | * |
Foreign Sales |  | 11.3 | % |  | 13.2 | % |  | 13.6 | %
* | less than 5%
The loss of any one of these customers could have a material adverse effect on the Company’s earnings and financial position. During the fiscal years November 30, 2016, 2015 and 2014, certain products within the Company’s product lines accounted for more than 10% of the Company’s net sales as follows:
|  | For the Year Ended November 30,
Category |  | 2016 |  | 2015 |  | 2014
Skin Care |  | 54.0 | % |  | 51.9 | % |  | 44.8 | %
Oral Care |  | 38.7 | % |  | 34.4 | % |  | 35.3 | %
Nail Care |  | * |  |  | 7.4 | % |  | 14.0 | %
* less than 10% |  |  |  |  |  |

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6327-108592 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13531-108611 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6404-108592 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 21 -URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6442-108592 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=51801978&loc=d3e6351-108592 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -URI http://asc.fasb.org/extlink&oid=49121117&loc=d3e13537-108611 + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RisksAndUncertaintiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration